Column Group L P is Director of NGM BIOPHARMACEUTICALS INC. Currently has a direct ownership of 0 shares of NGM, which is worth approximately $0. The most recent transaction as insider was on Mar 25, 2020, when has been sold 2,416 shares (Common Stock) at a price of $12.49 per share, resulting in proceeds of $30,176. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

COLUMN GROUP L P Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 25 2020
BUY
Open market or private purchase
$30,176 $12.49 p/Share
2,416 Added 0.23%
1,038,170 Common Stock
Mar 24 2020
BUY
Open market or private purchase
$1,568,767 $12.22 p/Share
128,377 Added 11.03%
1,035,754 Common Stock
Mar 23 2020
BUY
Open market or private purchase
$1,981,601 $11.63 p/Share
170,387 Added 15.81%
907,377 Common Stock
Mar 20 2020
BUY
Open market or private purchase
$1,684,075 $11.77 p/Share
143,082 Added 16.26%
736,990 Common Stock
Mar 19 2020
BUY
Open market or private purchase
$1,720,698 $11.59 p/Share
148,464 Added 20.0%
593,908 Common Stock
Mar 05 2020
BUY
Open market or private purchase
$149,526 $18.0 p/Share
8,307 Added 1.83%
445,444 Common Stock
Mar 04 2020
BUY
Open market or private purchase
$179,349 $17.96 p/Share
9,986 Added 2.23%
437,137 Common Stock
Mar 03 2020
BUY
Open market or private purchase
$697,256 $17.99 p/Share
38,758 Added 8.32%
427,151 Common Stock
Mar 02 2020
BUY
Open market or private purchase
$252,820 $17.9 p/Share
14,124 Added 3.51%
388,393 Common Stock
Feb 28 2020
BUY
Open market or private purchase
$676,998 $17.91 p/Share
37,800 Added 9.17%
374,269 Common Stock
Feb 27 2020
BUY
Open market or private purchase
$607,077 $17.91 p/Share
33,896 Added 9.15%
336,469 Common Stock
Feb 26 2020
BUY
Open market or private purchase
$67,518 $18.0 p/Share
3,751 Added 1.22%
302,573 Common Stock
Feb 06 2020
BUY
Open market or private purchase
$716,604 $15.96 p/Share
44,900 Added 13.06%
298,822 Common Stock
Nov 11 2019
BUY
Open market or private purchase
$180 $12.0 p/Share
15 Added 0.01%
253,922 Common Stock
Nov 04 2019
BUY
Open market or private purchase
$100,824 $11.99 p/Share
8,409 Added 3.21%
253,907 Common Stock
Oct 23 2019
BUY
Open market or private purchase
$24,752 $11.86 p/Share
2,087 Added 0.84%
245,498 Common Stock
Oct 22 2019
BUY
Open market or private purchase
$27,600 $12.0 p/Share
2,300 Added 0.94%
243,411 Common Stock
Oct 21 2019
BUY
Open market or private purchase
$518,196 $11.94 p/Share
43,400 Added 15.25%
241,111 Common Stock
Oct 18 2019
BUY
Open market or private purchase
$392,000 $11.29 p/Share
34,721 Added 14.94%
197,711 Common Stock
Oct 17 2019
BUY
Open market or private purchase
$72,407 $10.62 p/Share
6,818 Added 4.02%
162,990 Common Stock
Oct 16 2019
BUY
Open market or private purchase
$358,074 $10.26 p/Share
34,900 Added 18.27%
156,172 Common Stock
Oct 15 2019
BUY
Open market or private purchase
$342,292 $10.31 p/Share
33,200 Added 21.49%
121,272 Common Stock
Oct 14 2019
BUY
Open market or private purchase
$361,564 $10.36 p/Share
34,900 Added 28.38%
88,072 Common Stock
Oct 11 2019
BUY
Open market or private purchase
$187,343 $10.57 p/Share
17,724 Added 25.0%
53,172 Common Stock
Oct 10 2019
BUY
Open market or private purchase
$186,102 $10.5 p/Share
17,724 Added 33.33%
35,448 Common Stock

Also insider at

IMDZ
IMMUNE DESIGN CORP.
CNST
CONSTELLATION PHARMACEUTICALS INC Healthcare
NRIX
Nurix Therapeutics, Inc. Healthcare
CGL

Column Group L P

Director
San Francisco, CA

Track Institutional and Insider Activities on NGM

Follow NGM BIOPHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NGM shares.

Notify only if

Insider Trading

Get notified when an Ngm Biopharmaceuticals Inc insider buys or sells NGM shares.

Notify only if

News

Receive news related to NGM BIOPHARMACEUTICALS INC

Track Activities on NGM